Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06183255
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2023-12-05
Brief Title:
System Medicine Approach for Prevention Strategies for Comorbidities in Infertile Men
Sponsor:
IRCCS San Raffaele
Organization:
IRCCS San Raffaele
Study Overview
Official Title:
New System Medicine Approach for the Development of Primary Prevention Strategies for Comorbidities in Infertile Men
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
By applying a system medicine approach the project aims to identify new biomarkers andor prognostic tools aimed at developing personalized strategies to prevent the onset of comorbidities in infertile men
Detailed Description:
By applying a system medicine approach the project aims to identify new biomarkers andor prognostic tools aimed at developing personalized strategies to prevent the onset of comorbidities in infertile men
The findings will provide new insights into the relationship between male infertility and somatic health and shed light on the role of the microbiome in modulating the activity of the immune system A signature of lack of immunological tolerance and biomarkers could be useful to predict future oncologic and non-oncological comorbidities in infertile men This will let the development of a more clinically reliable and cost-effective personalized primarysecondary prevention strategy in a population at high risk of clinically relevant diseases
The findings will provide new insights into the relationship between male infertility and somatic health and shed light on the role of the microbiome in modulating the activity of the immune system A signature of lack of immunological tolerance and biomarkers could be useful to predict future oncologic and non-oncological comorbidities in infertile men This will let the development of a more clinically reliable and cost-effective personalized primarysecondary prevention strategy in a population at high risk of clinically relevant diseases
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None